title: Lopinavir/r versus nelfinavir as salvage therapy.
authors.forename: Salvador
authors.initials: S
authors.lastname: Resino
authors.forename: Alejandro
authors.initials: A
authors.lastname: Alvaro-Meca
authors.forename: Maria Isabel
authors.initials: MI
authors.lastname: de José
authors.forename: Maria Dolores
authors.initials: MD
authors.lastname: Gurbindo
authors.forename: José Tomás
authors.initials: JT
authors.lastname: Ramos
authors.forename: Pablo
authors.initials: P
authors.lastname: Martin-Fontelos
authors.forename: Maria Angeles
authors.initials: MA
authors.lastname: Muñoz-Fernández
mesh_terms: D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007223:Infant; D061466:Lopinavir; D019888:Nelfinavir / Q000008:administration & dosage / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000008:administration & dosage / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D016879:Salvage Therapy; D019562:Viral Load
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D018894:Reverse Transcriptase Inhibitors; D061466:Lopinavir; D019888:Nelfinavir